Treatment with abiraterone and enzalutamide does not overcome poor outcome from metastatic castration-resistant prostate cancer in men with the germline homozygous HSD3B1 c.1245C genotype
Titel:
Treatment with abiraterone and enzalutamide does not overcome poor outcome from metastatic castration-resistant prostate cancer in men with the germline homozygous HSD3B1 c.1245C genotype
Auteur:
Lu, C. Terbuch, A. Dolling, D. Yu, J. Wang, H. Chen, Y. Fountain, J. Bertan, C. Sharp, A. Carreira, S. Isaacs, W.B. Antonarakis, E.S. De Bono, J.S. Luo, J.